Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Human Vaccines

• Publication date

  2010-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/hv.6.1.10396PMID 19946222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-erythrocytic and asexual erythrocytic stage whole-organism malaria vaccines

  2010cited by this paper
• The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

  2009cited by this paper
• Further optimization of mouse spermatozoa evaporative drying techniques.

  2009cited by this paper
• The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.

  2009cited by this paper
• Live immunization against East Coast fever--current status.

  2009cited by this paper
• Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’

  2009cited by this paper
• Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

  2009cited by this paper
• Conserved Protective Mechanisms in Radiation and Genetically Attenuated uis3(-) and uis4(-) Plasmodium Sporozoites

  2009cited by this paper
• The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites.

  2008cited by this paper
• Gene Disruption of Plasmodium falciparum p52 Results in Attenuation of Malaria Liver Stage Development in Cultured Primary Human Hepatocytes

  2008cited by this paper
• A Sporozoite Asparagine-Rich Protein Controls Initiation of Plasmodium Liver Stage Development

  2008cited by this paper
• Chemical Attenuation of Plasmodium berghei Sporozoites Induces Sterile Immunity in Mice

  2008cited by this paper
• A new global malaria eradication strategy.

  2008cited by this paper
• Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.

  2008cited by this paper
• Bedlam in the blood: malaria

  2007cited by this paper
• The decline in paediatric malaria admissions on the coast of Kenya

  2007cited by this paper
• Plasmodium yoelii Sporozoites with Simultaneous Deletion of P52 and P36 Are Completely Attenuated and Confer Sterile Immunity against Infection

  2007cited by this paper
• Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine.

  2007cited by this paper
• Drying a tuberculosis vaccine without freezing

  2007cited by this paper
• Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity.

  2007cited by this paper
• Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in Zanzibar

  2007cited by this paper
• Direct Microscopic Quantification of Dynamics of Plasmodium berghei Sporozoite Transmission from Mosquitoes to Mice

  2007cited by this paper
• Pre-erythrocytic stage malaria vaccines: time for a change in path.

  2007cited by this paper
• Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland.

  2007cited by this paper
• Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.

  2007cited by this paper
• Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.

  2007cited by this paper
• Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

  2007cited by this paper
• Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.

  2007cited by this paper
• A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods

  2006cited by this paper
• ImmunoVEXtri-Melan: A Cancer Vaccine for Dendritic Cell Mediated Immunotherapy of Melanoma

  2005cited by this paper
• Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

  2005cited by this paper
• Non-small-cell lung cancer vaccine therapy: a concise review.

  2005cited by this paper
• Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.

  2005cited by this paper
• Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

  2005cited by this paper
• Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate‐pulsed cells: a phase I/II study

  2004cited by this paper
• Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data

  2003cited by this paper
• Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine

  2003cited by this paper
• Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines

  2002cited by this paper
• Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

  2002cited by this paper
• The Complexity of Protective Immunity Against Liver-Stage Malaria1 2

  2000cited by this paper
• Cholera vaccines.

  2000cited by this paper
• Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.

  1997cited by this paper
• Smallpox: The Triumph over the Most Terrible of the Ministers of Death

  1997cited by this paper
• Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2

  1995cited by this paper
• T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens.

  1995cited by this paper
• HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.

  1995cited by this paper
• Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.

  1993cited by this paper
• Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites.

  1993cited by this paper
• CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.

  1993cited by this paper
• Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.

  1991cited by this paper
• Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein.

  1991cited by this paper
• Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.

  1991cited by this paper
• Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.

  1990cited by this paper
• Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75.

  1990cited by this paper
• Human immunization with attenuated sporozoites.

  1990cited by this paper
• T cell responses in a sporozoite-immunized human volunteer and a chimpanzee.

  1990cited by this paper
• Progress in vaccines against typhoid fever.

  1989cited by this paper
• Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.

  1989cited by this paper
• CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

  1988cited by this paper
• Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro.

  1987cited by this paper
• [Preventive vaccination against tuberculosis: BCG].

  1984cited by this paper
• Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.

  1979cited by this paper
• Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man.

  1977cited by this paper
• Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

  1975cited by this paper
• Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum.

  1974cited by this paper
• Immunization of man against sporozite-induced falciparum malaria

  1973influential reference
• Specificity of protection of man immunized against sporozoite‐induced falciparum malaria

  1973influential reference
• Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

  1967cited by this paper

• The endemic dilemma: why whole sporozoite malaria vaccine efficacy falls in the field.

  2026cites this paper
• Successful insertion and expression of a tetracycline transactivator in Anopheles stephensi associated with increased egg production and decreased hatching rate

  2025cites this paper
• FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein.

  2025cites this paper
• Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanil

  2025cites this paper
• Successful insertion and expression of a tetracycline transactivator in Anopheles stephensi associated with increased egg production and decreased hatching rate

  2025influential citation
• A 3D culture model facilitates mass production of in vitro Plasmodium falciparum haemolymph-like sporozoites

  2025cites this paper
• Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions

  2025cites this paper
• Host Immune Response to Cryptosporidium spp.: Insights and Perspectives for Vaccine Development

  2025cites this paper
• Whole-sporozoite malaria vaccines: where we are, where we are going

  2024cites this paper
• A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion

  2024influential citation
• A Plasmodium late liver stage arresting GAP provides superior protection in mice

  2024cites this paper
• Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population

  2024cites this paper
• A conserved Plasmodium nuclear protein is critical for late liver stage development

  2024cites this paper
• A Review of Major Patents on Potential Malaria Vaccine Targets

  2023cites this paper
• Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle.

  2023cites this paper
• The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections

  2023cites this paper
• Malaria Vaccines: Progress to Date

  2023cites this paper
• Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults

  2023cites this paper
• Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects

  2023cites this paper
• Ifakara MasterClasses: lessons from leading experts on the battle against malaria.

  2023cites this paper
• Sporozoite immunization: innovative translational science to support the fight against malaria

  2023cites this paper
• A First for Human Vaccinology: GMP Compliant Radiation Attenuation of Plasmodium falciparum Sporozoites for Production of a Vaccine Against Malaria

  2022cites this paper
• Genetically modified malaria parasites as vaccine candidates.

  2022cites this paper
• Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults

  2022cites this paper
• A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria

  2022cites this paper
• Low Dose Gamma Irradiation of Trypanosoma evansi Parasites Identifies Molecular Changes That Occur to Repair Radiation Damage and Gene Transcripts That May Be Involved in Establishing Disease in Mice Post-Irradiation

  2022cites this paper
• Five decades of clinical assessment of whole-sporozoite malaria vaccines

  2022cites this paper
• In vitro production of infectious Plasmodium falciparum sporozoites

  2022cites this paper
• Immunoprofiling Identifies Functional B and T Cell Subsets Induced by an Attenuated Whole Parasite Malaria Vaccine as Correlates of Sterile Immunity

  2022cites this paper
• Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites

  2022cites this paper
• Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens

  2022cites this paper
• Current approaches to malaria vaccines.

  2022cites this paper
• Cryopreservation of Anopheles stephensi embryos

  2022cites this paper
• Differential Homing Receptor Profiles of Lymphocytes Induced by Attenuated versus Live Plasmodium falciparum Sporozoites

  2022cites this paper
• Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver

  2022cites this paper
• Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon

  2022cites this paper
• Engineered DNA-encoded monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein confer single dose protection in a murine malaria challenge model

  2022cites this paper
• Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens

  2022cites this paper
• Clonal evolution and TCR specificity of the human TFH cell response to Plasmodium falciparum CSP

  2022cites this paper
• Malaria Vaccines

  2022cites this paper
• A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection

  2022cites this paper
• Engineered DNA-encoded monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein confer single dose protection in a murine malaria challenge model

  2022cites this paper
• Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases.

  2021cites this paper
• Dissection-independent production of Plasmodium sporozoites from whole mosquitoes

  2021cites this paper
• PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

  2021cites this paper
• Identification of the Glycan Binding Profile of Human and Rodent Plasmodium Sporozoites.

  2021cites this paper
• Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

  2021cites this paper
• Towards a Method for Cryopreservation of Mosquito Vectors of Human Pathogens.

  2021cites this paper
• An efficient single‐cell based method for linking human T cell phenotype to T cell receptor sequence and specificity

  2021cites this paper
• The Search of a Malaria Vaccine: The Time for Modified Immuno-Potentiating Probes

  2021cites this paper
• Correlates of malaria vaccine efficacy

  2021influential citation
• Plasmodium falciparum: Experimental and Theoretical Approaches in Last 20 Years

  2021cites this paper
• Transient knockdown of Anopheles stephensi LRIM1 using RNAi increases Plasmodium falciparum sporozoite salivary gland infections

  2021cites this paper
• Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?

  2021cites this paper
• The challenges of a circumsporozoite protein-based malaria vaccine

  2021cites this paper
• Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.

  2021cites this paper
• Heat Shock Proteins as Targets for Novel Antimalarial Drug Discovery.

  2021cites this paper
• Knockout of Anopheles stephensi immune gene LRIM1 by CRISPR-Cas9 reveals its unexpected role in reproduction and vector competence

  2021cites this paper
• Conservation of S20 as an Ineffective and Disposable IFNγ-Inducing Determinant of Plasmodium Sporozoites Indicates Diversion of Cellular Immunity

  2021cites this paper
• Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea

  2021cites this paper
• Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque.

  2021cites this paper
• Incidence of Plasmodium Falciparum Malaria Infection in 6-month- to 45-year-olds on Bioko Island, Equatorial Guinea.

  2021cites this paper
• Development of Plasmodium‐specific liver‐resident memory CD8+ T cells after heat‐killed sporozoite immunization in mice

  2021cites this paper
• Clonal evolution and specificity of the human T follicular helper cell response to Plasmodium falciparum circumsporozoite protein

  2021cites this paper
• Pre-Erythrocytic Vaccines against Malaria

  2020cites this paper
• Malaria

  2020cites this paper
• Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.

  2020cites this paper
• Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination

  2020cites this paper
• Mapping of safe and early chemo-attenuated live Plasmodium falciparum immunization identifies immune signature of vaccine efficacy

  2020cites this paper
• Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya

  2020cites this paper
• IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents

  2020cites this paper
• Dissection-independent production of a protective whole-sporozoite malaria vaccine

  2020cites this paper
• Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum

  2020cites this paper
• Malaria vaccines since 2000: progress, priorities, products

  2020cites this paper
• Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

  2020cites this paper
• and its Role in One Health Approach: A Review

  2020cites this paper
• Anti-Plasmodial Effects of Ethanolic Extract of Florida Beggar Weed (Desmodiumtortuosum) on Albino Mice-Infected with Plasmodium Bergheiberghei

  2020cites this paper
• A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

  2020cites this paper
• The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa

  2020cites this paper
• A Mosquito Pick-and-Place System for PfSPZ-Based Malaria Vaccine Production

  2020cites this paper
• A replication-competent late liver stage-attenuated human malaria parasite.

  2020cites this paper
• Application of Radiation Technology: A Novel Vaccine Approach to Induce Protective Immunity against Malaria Infection

  2020cites this paper
• Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ Vaccine in Tanzanian adults.

  2019cites this paper
• Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial

  2019cites this paper
• Irradiation of intraerythrocytic Plasmodium berghei with a fractionated dose of gamma rays does not effectively reduce the infectivity in mice Mus musculus

  2019cites this paper
• Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection

  2019cites this paper
• Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential

  2019cites this paper
• You Shall Not Pass: Memory CD8 T Cells in Liver-Stage Malaria.

  2019cites this paper
• Automation of Mosquito Dissection for Malaria Vaccine Production Final Report

  2019cites this paper
• Bystander responses impact accurate detection of murine and human antigen-specific CD8 T cells.

  2019cites this paper
• An Efficient Production Process for Extracting Salivary Glands from Mosquitoes

  2019cites this paper
• Live Vaccines Against Plasmodium Preerythrocytic Stages.

  2019cites this paper
• Dissecting the CD8+ T cell responses to pre-erythrocytic malaria antigens

  2019cites this paper
• Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein

  2019cites this paper
• Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants

  2019cites this paper
• Is Saglin a mosquito salivary gland receptor for Plasmodium falciparum?

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• The Antibody Response to Plasmodium falciparum: Cues for Vaccine Design and the Discovery of Receptor-Based Antibodies.

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• Mosquito Staging Apparatus for Producing PfSPZ Malaria Vaccines

  2019cites this paper